Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

Shares in Novo Nordisk plunged 20% on Friday. Read More

https://fortune.com/img-assets/wp-content/uploads/2024/12/GettyImages-2160633003-e1734705498333.jpg?resize=1200,600

2024-12-20 14:46:24